Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia
Science Advances · 2025
DOI: 10.1126/sciadv.ads8351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Caroline R M Wiggers und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Galectins, Interferon Regulatory Factor-1, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Galectin-9 is overexpressed in a variety of cancers and associated with worse clinical outcome in some cancers. However, the regulators driving Galectin-9 expression are unknown. Here, we defined the transcriptional regulators and epigenetic circuitry of Galectin-9 in pediatric T cell acute lymphoblastic leukemia (T-ALL), as an example of a disease with strong Galectin-9 expression, in which higher expression was associated with lower overall survival. By performing a genome-wide CRISPR screen, we identified the transcription factors IRF1 and TFAP4 as key regulators for Galectin-9 expression by binding its regulatory elements. Whereas IRF1 was observed exclusively on the promoter, TFAP4 binding was detected at an enhancer solely in T-ALL cells associated with higher Galectin-9 levels. Together, our results show that IRF1 is responsible and indispensable for Galectin-9 expression and TFAP4 further fine-tunes its expression. Our approach, a flow-based genome-wide CRISPR screen complemented by transcription factor binding and enhancer mapping, creates innovative opportunities for understanding and manipulating epigenetic transcriptional regulation in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
ORCID-Profile: Caroline R M Wiggers, Burak Yüzügüldü, Nathanial G Tadros, Tayla B Heavican-Foral, Eugene Y Cho, Merve Ozdemir, Steffen B Kulp, Alejandro Gutierrez, Jens G Lohr, Birgit Knoechel
Förderung
- NCI NIH HHS
Zitieren
APA
Wiggers, C. R. M., Yüzügüldü, B., Tadros, N. G., Heavican-Foral, T. B., Cho, E. Y., Eisenbies, Z. C., Ozdemir, M., Kulp, S. B., Chae, Y. C., Gutierrez, A., Lohr, J. G., & Knoechel, B. (2025). Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. Science Advances. https://doi.org/10.1126/sciadv.ads8351
Vancouver
Wiggers CRM, Yüzügüldü B, Tadros NG, Heavican-Foral TB, Cho EY, Eisenbies ZC, et al. Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. Science Advances. 2025. doi:10.1126/sciadv.ads8351
BibTeX
@article{Wiggers2025,
author = {Wiggers, Caroline R M and Yüzügüldü, Burak and Tadros, Nathanial G and Heavican-Foral, Tayla B and Cho, Eugene Y and Eisenbies, Zachary C and Ozdemir, Merve and Kulp, Steffen B and Chae, Yun-Cheol and Gutierrez, Alejandro and Lohr, Jens G and Knoechel, Birgit},
title = {Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ads8351}
}
EUVIMED